{"title":"前列腺癌患者对药物级合成大麻二酚的客观反应报告","authors":"Julian Kenyon, A. Davies, C. Stott","doi":"10.47496/nl.crio.2020.01.06","DOIUrl":null,"url":null,"abstract":"This is an observational study of objective responses of Prostate Cancer patients to Pharmaceutical Grade\nSynthetic Cannabidiol. The total number of patients in the study was 12, 11 had a response of one kind or\nanother.\n","PeriodicalId":283301,"journal":{"name":"Case Reports and Images In Oncology","volume":"54 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2020-09-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Report of Objective Responses of Prostate Cancer Patients to Pharmaceutical Grade Synthetic Cannabidiol\",\"authors\":\"Julian Kenyon, A. Davies, C. Stott\",\"doi\":\"10.47496/nl.crio.2020.01.06\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"This is an observational study of objective responses of Prostate Cancer patients to Pharmaceutical Grade\\nSynthetic Cannabidiol. The total number of patients in the study was 12, 11 had a response of one kind or\\nanother.\\n\",\"PeriodicalId\":283301,\"journal\":{\"name\":\"Case Reports and Images In Oncology\",\"volume\":\"54 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-09-21\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Case Reports and Images In Oncology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.47496/nl.crio.2020.01.06\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Case Reports and Images In Oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.47496/nl.crio.2020.01.06","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Report of Objective Responses of Prostate Cancer Patients to Pharmaceutical Grade Synthetic Cannabidiol
This is an observational study of objective responses of Prostate Cancer patients to Pharmaceutical Grade
Synthetic Cannabidiol. The total number of patients in the study was 12, 11 had a response of one kind or
another.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
